Phase 2 Study Of The Response And Safety Of P-Bcma-101 Car-T Cells In Patients With Relapsed/Refractory (R/R) Multiple Myeloma (Mm) (Prime)Caitlin L. Costello,Tara K. Gregory,Syed Abbas Ali,Jesus G. Berdeja,Krina K. Patel,Nina D. Shah,Eric Ostertag,Chris Martin,Majid Ghoddusi,Devon J Shedlock,Matthew A. Spear,Robert Z. Orlowski,Adam D. CohenBLOOD(2019)引用 55|浏览21暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要